CTOR
Citius Oncology·NASDAQ
--
--(--)
--
--(--)
2.67 / 10
Underperform
Technical assessment rates Underperform at 2.67/10. Recent candlestick patterns show Long Upper and Lower Shadows, both bearish, with no bullish signals. The market appears weak, raising decline risk.
Analysis Checks(0/2)
Long Upper Shadow
Score2.31/10
Win Rate41.24%
Hist. Signals97
Avg Return1.26%
Score2.31/10
Win Rate41.24%
Hist. Signals97
Avg Return1.26%
Long Lower Shadow
Score3.03/10
Win Rate44.44%
Hist. Signals99
Avg Return1.72%
Score3.03/10
Win Rate44.44%
Hist. Signals99
Avg Return1.72%
Long Upper Shadow
Score2.31/10
Win Rate41.24%
Hist. Signals97
Avg Return1.26%
Score2.31/10
Win Rate41.24%
Hist. Signals97
Avg Return1.26%
Long Lower Shadow
Score3.03/10
Win Rate44.44%
Hist. Signals99
Avg Return1.72%
Score3.03/10
Win Rate44.44%
Hist. Signals99
Avg Return1.72%
Technical Analysis of CTOR?
- CTOR presents a Underperform setup with a Technical Score of 2.67/10. Key technical indicators highlight an RSI of 36.43 and a MACD of -0.00, with the trend anchored by the 50-Day SMA at 0.97. Traders should monitor key support at 0.53 and resistance at 0.68.
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
